Previous close | 15.21 |
Open | 15.30 |
Bid | 15.21 x 200 |
Ask | 15.26 x 500 |
Day's range | 15.11 - 15.53 |
52-week range | 15.11 - 33.99 |
Volume | |
Avg. volume | 1,901,554 |
Market cap | 2.52B |
Beta (5Y monthly) | 0.42 |
PE ratio (TTM) | ∞ |
EPS (TTM) | 0.00 |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 27.39 |
ACADIA's Revenue Surges with Strong Sales from NUPLAZID and DAYBUE
ACADIA Pharmaceuticals ( NASDAQ:ACAD ) First Quarter 2024 Results Key Financial Results Revenue: US$205.8m (up 74% from...
SAN DIEGO, May 09, 2024--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at three upcoming investor conferences: